Fujifilm secures funding, signs lease for new research/manufacturing center

By The Science Advisory Board staff writers

Fujifilm Diosynth Biotechnologies has announced $76 million in financing for the Center for Advanced Biological Innovation and Manufacturing (CABIM) and that a lease for a site in the Boston area has been signed.

CABIM is an industry-academia research and development consortium aimed at accelerating development and commercialization of cell and gene therapy, gene editing, and immunotherapy. In addition to Fujifilm, it is backed by the following:

  • Harvard University
  • Massachusetts Institute of Technology
  • Cytiva
  • Alexandria Real Estate Equities

The lease covers a 40,000-sq-ft site at the Arsenal on the Charles business park in Watertown MA, which is owned and operated by Alexandria Real Estate. The $76 million in fundraising will be used to help build the site, support 40 full-time employees, and maintain daily operations. The new center is set to open early next year

Fujifilm Diosynth Biotechnologies, a contract development and management organization subsidiary of Fujifilm, is set to provide contract development and manufacturing services.

Copyright © 2021 scienceboard.net

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking